Pharmafile Logo
Pharmafocus logo
Advanced Search

Nesina

Showing 3 posts of 3 posts found.

FDA image

AZ and Takeda diabetes drugs get FDA safety update

April 15, 2015
Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Nesina, Onglyza, Takeda, alogliptin, cardiovascular, diabetes, saxagliptin

An FDA advisory committee has said that the labels of two type 2 diabetes drugs should be changed to warn …

News
Astrazeneca image

AstraZeneca diabetes drug could ‘significantly’ increase mortality

April 13, 2015
Research and Development, Sales and Marketing AstraZeneca, FDA, Nesina, Onglyza, Takeda, alogliptin, cardiovascular, saxagliptin

AstraZeneca’s diabetes drug Onglyza may lead to a ‘significant increase’ in risk of death according to a new analysis from …

News
Takeda HQ image

Takeda gets US diabetes approval

January 28, 2013
Sales and Marketing FDA, Nesina, Takeda, diabetes

Takeda has been given US approval for its diabetes drug Nesina and two variations on it for the treatment of …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025